These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18024612)

  • 21. [Research Advance of Microparticles in Hypercoagulation of Hemolytic Anemia-Review].
    Su X; Cheng P; Deng DH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):622-626. PubMed ID: 28446324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease.
    Sakamoto TM; Canalli AA; Traina F; Franco-Penteado CF; Gambero S; Saad ST; Conran N; Costa FF
    Clin Biochem; 2013 Dec; 46(18):1798-803. PubMed ID: 24060729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathophysiology of disease in patients with paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hiken J
    Hematology Am Soc Hematol Educ Program; 2008; ():104-10. PubMed ID: 19074066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemolytic anemias and vitamin B12 deficieny].
    Dietzfelbinger H; Hubmann M
    Dtsch Med Wochenschr; 2015 Aug; 140(17):1302-10; quiz 1311-2. PubMed ID: 26306021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
    Nishimura J; Smith CA; Phillips KL; Ware RE; Rosse WF
    Hematopathol Mol Hematol; 1998; 11(3-4):119-46. PubMed ID: 9844822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemolytic anemias. Diagnosis and management.
    Tabbara IA
    Med Clin North Am; 1992 May; 76(3):649-68. PubMed ID: 1578962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders.
    Risitano AM
    Immunobiology; 2012 Nov; 217(11):1080-7. PubMed ID: 22964233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
    Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.
    Gladwin MT; Kato GJ
    Hematology Am Soc Hematol Educ Program; 2005; ():51-7. PubMed ID: 16304359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paroxysmal nocturnal hemoglobinuria: the price for a chance.
    Bessler M
    Schweiz Med Wochenschr; 1996 Nov; 126(45):1912-21. PubMed ID: 8946596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.
    George JN; Charania RS
    Semin Thromb Hemost; 2013 Mar; 39(2):153-60. PubMed ID: 23390027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood cells diseases and thrombosis.
    Leone G; Sica S; Chiusolo P; Teofili L; De Stefano V
    Haematologica; 2001 Dec; 86(12):1236-44. PubMed ID: 11726314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of thrombotic microangiopathies with plasma exchange.
    Basic-Jukic N; Kes P; Bubic-Filipi L; Brunetta B
    Hematology; 2007 Feb; 12(1):63-7. PubMed ID: 17364995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
    Röth A; Dührsen U
    Eur J Haematol; 2011 Dec; 87(6):473-9. PubMed ID: 21883481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent advances in research on paroxysmal nocturnal hemoglobinuria].
    Kinoshita T
    Rinsho Ketsueki; 1993 May; 34(5):529-36. PubMed ID: 8315823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD55 and CD59 deficiency in transplant patient populations: possible association with paroxysmal nocturnal hemoglobinuria-like symptoms in Campath-treated patients.
    Ruiz P; Weppler D; Tryphonopoulos P; Nishida S; Moon J; Kato T; Selvaggi G; Levi D; Madariaga J; DelaGarza J; Tuteja S; Garcia M; Tzakis A
    Transplant Proc; 2006; 38(6):1750-2. PubMed ID: 16908271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paroxysmal nocturnal hemoglobinuria.
    Smith LJ
    Clin Lab Sci; 2004; 17(3):172-7. PubMed ID: 15314892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robust in vitro replication of Plasmodium falciparum in glycosyl-phosphatidylinositol-anchored membrane glycoprotein-deficient red blood cells.
    Pattanapanyasat K; Walsh DS; Yongvanitchit K; Piyawatthanasakul N; Wanachiwanawin W; Webster HK
    Am J Trop Med Hyg; 2003 Oct; 69(4):360-5. PubMed ID: 14640493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aquired immune hemolytic anemias].
    Salama A
    Ther Umsch; 2004 Feb; 61(2):178-86. PubMed ID: 15018403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.
    Schmidtko J; Peine S; El-Housseini Y; Pascual M; Meier P
    Am J Kidney Dis; 2013 Feb; 61(2):289-99. PubMed ID: 23141475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.